MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuits
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mechanisms controlling resolution of acute inflammation are of wide interest. Here, we investigated microRNAs (miRNAs) in self‐limited acute inflammatory exudates and their regulation by resolvin D1 (RvD1). Using real‐time PCR analysis, we found in resolving exudates that miR‐21, miR‐146b, miR‐208a, miR‐203, miR‐142, miR‐302d, and miR‐219 were selectively regulated ( P <0.05) in self‐limited murine peritonitis. RvD1 (300 ng/mouse or 15 µgkg ‐1 ) reduced zymosan‐elicited neutrophil infiltration into the peritoneum 25–50% and shortened the resolution interval (ß i )by ~4 h. In peritonitis at 12 h, RvD1 up‐regulated miR‐21, miR‐146b, and miR‐219 and down‐regulated miR‐208a in vivo. In human macrophages overexpressing recombinant RvD1 receptors ALX/FPR2 or GPR32, these same miRNAs were significantly regulated ( P <0.05) by RvD1 at concentrations as low as 10 nM, recapitulating the in vivo circuit. In addition, RvD1‐miRNAs identified herein target cytokines and proteins involved in the immune system, e.g. , miR‐146b targeted NF‐κB signaling, and miR‐219 targeted 5‐lipoxygenase and reduced leukotriene production. RvD1 also reduced nuclear translocation of NF‐κB and SMAD and down‐regulated phospho‐IκB. Taken together, these results indicate that resolvin‐regulated specific miR‐NAs target genes involved in resolution and establish a novel resolution circuit involving RvD1 receptor‐dependent regulation of specific miRNAs.—Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., and Serhan, C. N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1‐miRNA circuits. FASEB J. 25, 544–560 (2011). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Naga Prasad, S. V., Duan, Z.-H., Gupta, M. K., Surampudi, V. S. K., Volinia, S., Calin, G. A., Liu, C.-G., Kotwal, A., Moravec, C. S., Starling, R. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036541 · Cited by 140
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · cited 1×
“Interestingly, the endonuclease Dicer, which is critical for processing precursors pri-miRNA into mature hairpin miRNAs (27), also binds 5-LO via its C-terminal domain.”
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“mation, cancer (10), and atherosclerosis (11).”
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233 · cited 1×
“miRNA 219 down-regulates 5-LO, an essential enzyme involved in the biosynthesis of both leukotrienes and lipoxins (44), as well as D-series resolvins from DHA (15).”
BackgroundSelf-citationNathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 7×
“miRNA 219 down-regulates 5-LO, an essential enzyme involved in the biosynthesis of both leukotrienes and lipoxins (44), as well as D-series resolvins from DHA (15).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 1
- 23. Majno G., Cotran R. S., Kaufman N., eds (1982) Current Topics in Inflammation and Infection, Vol. 23, Williams & Wilkins, Baltimore [Google Scholar]
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
The role of macrophages in the resolution of inflammation
Watanabe, S., Alexander, M., Misharin, A. V., & Budinger, G. R. S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124615 · Cited by 925
MicroRNAs: the fine-tuners of Toll-like receptor signalling
O'Neill, L. A., Sheedy, F. J., & McCoy, C. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2957 · Cited by 856
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
“These SPMs display potent receptor-mediated cell-specific actions (TABLE 1) .”
BackgroundResolution of inflammation: an integrated view
Ortega‐Gómez, A., Perretti, M., & Soehnlein, O. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202382 · Cited by 733
“Furthermore, resolvin E1 reduces neutrophil infiltration in murine peritonitis and shortens the resolution interval while modifying the expression of miRNAs that target genes involved in resolution (Recchiuti et al, 2011).”
MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease
Bhaskaran, M., & Mohan, M. (2014) · Veterinary Pathology · doi:10.1177/0300985813502820 · Cited by 605
Lipid Mediators in the Resolution of Inflammation
Serhan, C. N., Chiang, N., Dalli, J., & Levy, B. D. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016311 · Cited by 544
“2012) Peritonitis RvD1 Limits PMN recruitment and accelerate resolution (Recchiuti et al. 2011; Norling et al. 2012) Dry eye RvE1 and analog Protect from goblet cell loss (de Paiva et al.”
BackgroundInfluentialSelf-citationTurning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response
Sheedy, F. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00019 · Cited by 496
MicroRNA-181b regulates NF-κB–mediated vascular inflammation
Sun, X., Icli, B., Wara, A. K., Belkin, N., He, S., Kobzik, L., Hunninghake, G. M., Vera, M. P., Blackwell, T. S., Baron, R. M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61495 · Cited by 444
“Accumulating studies have reported that miRNA can be detected in the plasma and other body fluids (65–67).”
The role of lipoxygenases in pathophysiology; new insights and future perspectives
Mashima, R., & Okuyama, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.006 · Cited by 415
Natural resolution of inflammation
Freire, M. O., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/prd.12034 · Cited by 388
Emerging roles of resolvins in the resolution of inflammation and pain
Ji, R.-R., Xu, Z.-Z., Strichartz, G., & Serhan, C. N. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.005 · Cited by 344
“Peritonitis Stop neutrophil recruitment and modulate miRNAs [68]”
BackgroundSelf-citationResolution phase lipid mediators of inflammation: agonists of resolution
Serhan, C. N., & Chiang, N. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.012 · Cited by 331
“Hence, 5-LOX is a target gene of miR-219 [58].”
BackgroundSelf-citationChiang, N., & Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.005 · Cited by 324
“…nanoparticles Reduces ψmax accelerates T50 shortens Ri (Norling et al., 2011) Zymosan peritonitis RvD1 (ip) Reduces ψmax, accelerates T50, shortens Ri (Recchiuti et al., 2011) E. coli peritonitis RvD1 Ciprofloxacin Reduces ψmax accelerates T50 shortens Ri (Chiang et al., 2012) Allergic airway…”
BackgroundSelf-citationDas, A., Ganesh, K., Khanna, S., Sen, C. K., & Roy, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300613 · Cited by 320
A trio of microRNAs that control Toll-like receptor signalling
Quinn, S. R., & O'Neill, L. A. (2011) · International Immunology · doi:10.1093/intimm/dxr034 · Cited by 314
Resolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
“TGFβ, IL-10) that accumulate in resolving exudates (11, 19); microRNA changes (19); glucocorticoids and the glucocorticoid-induced annexin A1 protein, which also regulates inflammatory responses (reviewed in (42)); and the transcription factor NF-κB, which can display anti-inflammatory properties (43).”
BackgroundInfluentialSelf-citationDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
“, 2005), RvD1 (Norling et al., 2012; Recchiuti et al., 2011), and MaR1 (Serhan et al.”
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Fredman, G., & Serhan, C. N. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.01.028 · Cited by 283
“Actions of RvD1 in vivo are mediated, in part, by molecular circuits involving microRNAs (miRNAs) miR146b, miR-219, and miR-208a and their target genes, which are regulated by these receptors.(28) miRNAs are emerging as key regulators of the immune response and inflammation-related diseases such as cancer.”
BackgroundMethodInfluentialSelf-citationNegative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b
Curtale, G., Mirolo, M., Renzi, T. A., Rossato, M., Bazzoni, F., & Locati, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219852110 · Cited by 277
“Further research is required to understand whether miR-146b truly serves as a molecular switch involved in the resolution of inflammation, but it is interesting to note that this miR has been reported to be expressed during the resolution phase in a murine model of acute inflammation (33).”
BackgroundMas, E., Croft, K. D., Zahra, P., Barden, A., & Mori, T. A. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.190199 · Cited by 270
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Weylandt, K. H., Chiu, C.-Y., Gomolka, B., Waechter, S. F., & Wiedenmann, B. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.005 · Cited by 258
Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.001 · Cited by 257
“, 2008), which evoke rapid intracellular signaling and long-term actions via regulating specific miR involved in resolution of inflammation (Krishnamoorthy et al., 2012; Recchiuti et al., 2011).”
BackgroundInfluentialSelf-citationNorling, L. V., Dalli, J., Flower, R. J., Serhan, C. N., & Perretti, M. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.249508 · Cited by 249
“shown to modulate a repertoire of mediators and pathways via miRNAs, including the enzyme 5-lipoxygenase.(36) Thus, per-”
Self-citationNew pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
Serhan, C. N., Chiang, N., & Dalli, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 245
“RvD1 and RvD5 activate GPR32 (DRV1) in humans (Krishnamoorthy et al., 2010; Recchiuti et al., 2011; Chiang et al., 2012), RvD2 activates GPR18 (DRV2) (Chiang et al.”
Self-citationResolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
Dalli, J., Winkler, J. W., Colas, R. A., Arnardottir, H., Cheng, C.-Y. C., Chiang, N., Petasis, N. A., & Serhan, C. N. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.11.010 · Cited by 243
“, 2011) and stimulating resolution mechanisms in vivo in mice and with human macrophages in vitro (Recchiuti et al., 2011) as well as RvD1 identification in human blood (Mas et al.”
BackgroundSelf-citationResolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Rogerio, A. P., Haworth, O., Croze, R., Oh, S. F., Uddin, M., Carlo, T., Pfeffer, M. A., Priluck, R., Serhan, C. N., & Levy, B. D. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101665 · Cited by 232
“rived from DHA and has recently been identified to inhibit neutrophil activation (9–11), regulate cytokines (12, 13), and protect after ischemia-reperfusion second organ injury (14, 15) and LPS-”
BackgroundSelf-citationUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Bäck, M., Powell, W. S., Dahlén, S., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., & Rovati, G. E. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12665 · Cited by 217
“This RvD1–GPR32 interaction in human macrophages stimulated miRNA involved in resolution of inflammatory signals (Recchiuti et al., 2011; Recchiuti and Serhan, 2012).”
BackgroundSelf-citationRossato, M., Curtale, G., Tamassia, N., Castellucci, M., Mori, L., Gasperini, S., Mariotti, B., De Luca, M., Mirolo, M., Cassatella, M. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209100109 · Cited by 215
Hsiao, H.-M., Sapinoro, R. E., Thatcher, T. H., Croasdell, A., Levy, E. P., Fulton, R. A., Olsen, K. C., Pollock, S. J., Serhan, C. N., Phipps, R. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058258 · Cited by 209
“It was recently reported that RvD1 regulates pro- and antiinflammatory micro RNAs via signaling through its G-protein receptors ALX and GPR32, resulting in increased production of IL-10 and decreased NF-kB activity [51].”
BackgroundSelf-citationResolvin E2 Formation and Impact in Inflammation Resolution
Oh, S. F., Dona, M., Fredman, G., Krishnamoorthy, S., Irimia, D., & Serhan, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103652 · Cited by 189
“In this regard, resolvin D1 regulates inflammation-proresolving pathways by upregulating specific miRNA in a receptor-dependent fashion; for example, miR146b targeting NF-kB (51).”
BackgroundSelf-citationMicroRNAs as Molecular Switches in Macrophage Activation
Curtale, G., Rubino, M., & Locati, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00799 · Cited by 182
Zhang, M. J., & Spite, M. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150726 · Cited by 171
“Finally, a unique and recent investigation profiled micro (mi) RNA expression dynamics during RvD1-stimulated resolution of acute inflammation (86).”
BackgroundThe Atlas of Inflammation Resolution (AIR)
Serhan, C. N., Gupta, S. K., Perretti, M., Godson, C., Brennan, E., Li, Y., Soehnlein, O., Shimizu, T., Werz, O., Chiurchiù, V., et al. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100894 · Cited by 169
Self-citationLipoxin and Resolvin Receptors Transducing the Resolution of Inflammation in Cardiovascular Disease
Pirault, J., & Bäck, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01273 · Cited by 165
“DRV1/GPR32 is expressed in human macrophages (Schmid et al., 2016) in which it increases phagocytosis (Chiang et al., 2012) and miRNAs involved in proresolving signaling (Recchiuti et al., 2011; Recchiuti and Serhan, 2012) in response to RvD1.”
Novel Resolvin D2 Receptor Axis in Infectious Inflammation
Chiang, N., de la Rosa, X., Libreros, S., & Serhan, C. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601650 · Cited by 161
“volved in resolution of inflammation, including IkB kinase, IL-10, and 5-lipoxygenase in an ALX- and DRV1/GPR32-dependent manner (53).”
BackgroundSelf-citationFredman, G., & Serhan, C. N. (2011) · Biochemical Journal · doi:10.1042/bj20110327 · Cited by 158
Self-citationResolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
Rey, C., Nadjar, A., Buaud, B., Vaysse, C., Aubert, A., Pallet, V., Layé, S., & Joffre, C. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.013 · Cited by 176
Nutrimiromics: Role of microRNAs and Nutrition in Modulating Inflammation and Chronic Diseases
Quintanilha, B. J., Reis, B. Z., Duarte, G. B. D. S., Cozzolino, S. M. F., & Rogero, M. M. (2017) · Nutrients · doi:10.3390/nu9111168 · Cited by 168
“[113] verified that miR-21, miR-146b, miR-142 family, miR-203, miR-208a, miR-219, and miR-302d that are temporally and differentially expressed in resolving exudates, and Resolvin D1, which is biosynthesized in resolution, regulates miR-21, miR-146b, miR-208a, and miR-219.”
BackgroundRecchiuti, A., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00298 · Cited by 149
“Our recent results uncovered roles of miRNAs in self-limited inflammation and in the resolution phase, specifically, RvD1-G-protein coupled receptor-dependent gene networks in resolution of acute inflammation as part of the endogenous circuitry that controls this active process (Recchiuti et al., 2011; Krishnamoorthy…”
BackgroundInfluentialSelf-citationFrank, A.-C., Ebersberger, S., Fink, A. F., Lampe, S., Weigert, A., Schmid, T., Ebersberger, I., Syed, S. N., & Brüne, B. (2019) · Nature Communications · doi:10.1038/s41467-019-08989-2 · Cited by 157
N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 147
“…different biological roles: miR-21 is essential to the production of anti-inflammatory cytokine IL-10, miR-146 regulates the transcription of cytokines, chemokines and their receptor, miR-219 decreases the transcription of TNF-α and miR208a regulates the activation of NFkB (Recchiuti et al., 2011).”
BackgroundInfluentialRodosthenous, R. S., Coull, B. A., Lu, Q., Vokonas, P., Schwartz, J. D., & Baccarelli, A. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0121-0 · Cited by 144
Balbi, C., Piccoli, M., Barile, L., Papait, A., Armirotti, A., Principi, E., Reverberi, D., Pascucci, L., Becherini, P., Varesio, L., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0297 · Cited by 144
Li, Y., Dalli, J., Chiang, N., Baron, R. M., Quintana, C., & Serhan, C. N. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.011 · Cited by 126
“Inhibition of AP-1 andNF-kB1 also led to downregulation of other resolution-related miRNAs (Recchiuti et al., 2011), including miR-146b, miR-208, and miR-219-2-3p (Figure 7D, right panel).”
InfluentialSelf-citationFang, L., Du, W. W., Yang, X., Chen, K., Ghanekar, A., Levy, G., Yang, W., Yee, A. J., Lu, W., Xuan, J. W., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-220905 · Cited by 123
Fredman, G., Li, Y., Dalli, J., Chiang, N., & Serhan, C. N. (2012) · Scientific Reports · doi:10.1038/srep00639 · Cited by 122
Self-citationmiRNA in Wound Inflammation and Angiogenesis
ROY, S., & SEN, C. K. (2012) · Microcirculation · doi:10.1111/j.1549-8719.2011.00156.x · Cited by 120
“Recently, the anti-inflammatory lipid mediator Resolvin D1 has been shown to modify the expression of miRNAs such as miR-21, miR-146b, miR-208a, and miR-219 [49].”
BackgroundSuresh Babu, S., Thandavarayan, R. A., Joladarashi, D., Jeyabal, P., Krishnamurthy, S., Bhimaraj, A., Youker, K. A., & Krishnamurthy, P. (2016) · Scientific Reports · doi:10.1038/srep36207 · Cited by 119
“…has been well studied, the contributions of these ligands in cardiomyocyte efferocytosis under diabetic condition remains to be explored. microRNAs (miR) have been shown to regulate a range of biological processes during development and disease, including inflammation and wound healing 5 .”
Kim, J., Okla, M., Erickson, A., Carr, T., Natarajan, S. K., & Chung, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721480 · Cited by 119
“(35) demonstrated that the anti-inflammatory role of resolvin, n-3 PUFAderived eicosanoids, is associated with specific miRNA target genes involved in resolution of acute inflammation (e.”
BackgroundBisicchia, E., Sasso, V., Catanzaro, G., Leuti, A., Besharat, Z. M., Chiacchiarini, M., Molinari, M., Ferretti, E., Viscomi, M. T., & Chiurchiù, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0889-z · Cited by 117
“These microRNAs, together with others such as miR-21 and miR-208a, and in turn their target genes, seem to belong to a complex network of regulatory molecules that promote resolution of acute inflammation [23].”
BackgroundChiang, N., Shinohara, M., Dalli, J., Mirakaj, V., Kibi, M., Choi, A. M. K., & Serhan, C. N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202969 · Cited by 117
“For example, in murine peritonitis, RvE1 accelerates the onset of resolution (Tmax), whereas PD1 and RvD1 shorten the resolution interval (Ri) (19, 28).”
BackgroundSelf-citationMallick, R., Basak, S., & Duttaroy, A. K. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101116 · Cited by 135
Integrated Genomic Analyses in Bronchopulmonary Dysplasia
Ambalavanan, N., Cotten, C. M., Page, G. P., Carlo, W. A., Murray, J. C., Bhattacharya, S., Mariani, T. J., Cuna, A. C., Faye-Petersen, O. M., Kelly, D. R., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.09.052 · Cited by 121
Noncoding RNAs: New Players in Chronic Pain
Lutz, B. M., Bekker, A., & Tao, Y. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000265 · Cited by 121
Noncoding RNAs: key molecules in understanding and treating pain
Bali, K. K., & Kuner, R. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.006 · Cited by 114
López‐Vicario, C., Rius, B., Alcaraz‐Quiles, J., García‐Alonso, V., Lopategi, A., Titos, E., & Clària, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.092 · Cited by 127
“from a murine model of peritonitis (Recchiuti et al., 2011).”
ResultDocosahexaenoic acid, 22:6n‐3: Its roles in the structure and function of the brain
Mallick, R., Basak, S., & Duttaroy, A. K. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.10.004 · Cited by 125
“The neuroprotectors, resolvin D1, and aspirin-triggered resolvin D1 improve brain functions and impair neuronal death by downregulating NF-kB, TLR4, CD200, and IL6R (Bisicchia et al., 2018; Recchiuti et al., 2010).”
BackgroundOmega-3 fatty acids and cognitive function
Welty, F. K. (2022) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000862 · Cited by 136
“NPD-1, resolvin D1 and aspirin-triggered resolvin D1 improve brain function and impair neuronal death through downregulation of NF-kB, TLR4, CD200 and IL6R [54,55].”
BackgroundMicroRNAs and the resolution phase of inflammation in macrophages
Alam, M. M., & O'Neill, L. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141740 · Cited by 109
Rius, B., Titos, E., Morán‐Salvador, E., López‐Vicario, C., García‐Alonso, V., González‐Périz, A., Arroyo, V., & Claria, J. (2014) · The FASEB Journal · doi:10.1096/fj.13-235614 · Cited by 107
“These changes were confirmed by measuring the protein expression of COX-2 and IL-1 in the PCLSs by Western blot analysis (Fig.”
BackgroundInfluentialCodagnone, M., Cianci, E., Lamolinara, A., Mari, V. C., Nespoli, A., Isopi, E., Mattoscio, D., Arita, M., Bragonzi, A., Iezzi, M., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.36 · Cited by 111
Self-citationSharma, S., Liu, J., Wei, J., Yuan, H., Zhang, T., & Bishopric, N. H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200234 · Cited by 108
Barnig, C., Bezema, T., Calder, P. C., Charloux, A., Frossard, N., Garssen, J., Haworth, O., Dilevskaya, K., Levi‐Schaffer, F., Lonsdorfer‐Wolf, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01699 · Cited by 121
“MiRs 21, 146b, 208a, and 219 are increased during the resolution phase of acute resolving peritonitis in mice (125) and RvD1 can regulate expression of these proresolving MiRs (126).”
BackgroundCooley, N., Cowley, M. J., Lin, R. C. Y., Marasco, S. F., Wong, C. Y., Kaye, D. M., Dart, A. M., & Woodcock, E. A. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00111.2011 · Cited by 97
Basak, S., Mallick, R., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2021) · Nutrients · doi:10.3390/nu13062061 · Cited by 104
“Both resolvin D1 and aspirin-triggered resolvin D1 improve brain functions and impede neuronal death by down-regulating several fac- tors such as NFkB, TLR4, CD200, and IL6R [136,137].”
BackgroundLiu, Y., Zhang, J., Han, R., Liu, H., Sun, D., & Liu, X. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.05.042 · Cited by 92
MicroRNA expression altered by diet: Can food be medicinal?
Palmer, J. D., Soule, B. P., Simone, B. A., Zaorsky, N. G., Jin, L., & Simone, N. L. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.04.005 · Cited by 100
Hulsmans, M., Dooren, E. V., Mathieu, C., & Holvoet, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032794 · Cited by 103
“Moreover, miR-146b-5p is induced by the anti-inflammatory lipid mediator resolvin D1 in human macrophages implying that this miR is a key player in the resolution of inflammation by mediating the removal of components of the NFkB signaling pathway [32].”
BackgroundResolution metabolomes activated by hypoxic environment
Norris, P. C., Libreros, S., & Serhan, C. N. (2019) · Science Advances · doi:10.1126/sciadv.aax4895 · Cited by 90
Self-citationBiased perspectives on formyl peptide receptors
Raabe, C. A., Gröper, J., & Rescher, U. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.11.015 · Cited by 90
microRNAs in nociceptive circuits as predictors of future clinical applications
Kress, M., Hüttenhofer, A., Landry, M., Kuner, R., Favereaux, A., Greenberg, D., Bednarik, J., Heppenstall, P., Kronenberg, F., Malcangio, M., et al. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00033 · Cited by 84
“Microglia and macrophage activity is suppressed by specific miRNAs, e.g., miR124, and it is therefore anticipated that miRNA regulation is critically involved in endogenous inhibition and resolution of inflammation by e.g., resolvins (Ponomarev et al., 2011; Recchiuti et al., 2011).”
BackgroundResolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
Isopi, E., Mattoscio, D., Codagnone, M., Mari, V. C., Lamolinara, A., Patruno, S., D’Aurora, M., Cianci, E., Nespoli, A., Franchi, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00581 · Cited by 86
Self-citationResolvin D1 Reduces Emphysema and Chronic Inflammation
Hsiao, H.-M., Thatcher, T. H., Colas, R. A., Serhan, C. N., Phipps, R. P., & Sime, P. J. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.008 · Cited by 82
“1360 1361 1362 1363 byRvD1.(11,48) Previously, we reported that RvD1 attenuated the production of the neutrophil chemoattractant IL-8 by human lung epithelial cells by inhibiting the activation of NF-kB and mitogen-activated protein kinase.”
Self-citationSun, W., Ma, J., Zhao, H., Xiao, C., Zhong, H., Ling, H., Xie, Z., Tian, Q., Chen, H., Zhang, T., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2133-2 · Cited by 89
“MicroRNAs (miRNAs) are a family of small noncoding RNAs that usually downregulate gene expression through targeting the 3′-UTR of mRNA [14].”
BackgroundStrategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury
Lee, T. J., Yuan, X., Kerr, K. M., Yoo, J. Y., Kim, D., Kaur, B., & Eltzschig, H. K. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.019026 · Cited by 80
“…’ s laboratory found that resolvin D1 (RvD1) selectively upregulates miRNAs such as miR-21, miR-146b, and miR-219 and down-regulates miR-208a, resulting in the reduction in the activity of nuclear factor kappa B and mothers against decapentaplegic family in macrophages (Recchiuti et al., 2011).”
Background15-epi-Lipoxin A4, Resolvin D2, and Resolvin D3 Induce NF-κB Regulators in Bacterial Pneumonia
Sham, H. P., Walker, K. H., Abdulnour, R.-E. E., Krishnamoorthy, N., Douda, D. N., Norris, P. C., Barkas, I., Benito-Figueroa, S., Colby, J. K., Serhan, C. N., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1602090 · Cited by 78
“kB through micro RNA circuits (21), providing multiple cellular mechanisms for SPMs to control NF-kB.”
BackgroundSelf-citationQin, C. X., Norling, L. V., Vecchio, E. A., Brennan, E. P., May, L. T., Wootten, D. L., Godson, C., Perretti, M., & Ritchie, R. H. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15919 · Cited by 88
“…of FPR2 agonism, including LXA4-mediated up-regulation of lethal-7 (let-7) and mir-126-5p gene expression (Brennan et al., 2013, 2017; Codagnone et al., 2017) and RvD1-mediated regu- lation of miR-21, miR-146b, miR-219 and miR-155 (Rajasagi et al., 2017; Recchiuti et al., 2011).”
Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
Markworth, J. F., Brown, L. A., Lim, E. Y., Floyd, C., Larouche, J. A., Castor‐Macias, J. A., Sugg, K. B., Sarver, D. C., Macpherson, P. C. D., Davis, C. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137713 · Cited by 85
Sproviero, D., Gagliardi, S., Zucca, S., Arigoni, M., Giannini, M., Garofalo, M., Olivero, M., Dell’Orco, M., Pansarasa, O., Bernuzzi, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052737 · Cited by 75
“hsa-miR-199a-5p and hsa-miR-329a-5p regulate LCN2, lipocalin2, inducible factor secreted by reactive astrocytes in transgenic rats with neuronal expression of mutant human TDP-43 or RNA-binding protein FUS and that is selectively toxic to neurons [34] (Figure 5a); (2) for LEVs from FTD patients regulation of genes lik…”
BackgroundAbdelmoaty, S., Wigerblad, G., Bas, D. B., Codeluppi, S., Fernández-Zafra, T., El‐Awady, E., Moustafa, Y. M., Abdelhamid, A. E.-D. S., Brodin, E., & Svensson, C. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075543 · Cited by 79
“From an intracellular perspective, signaling through the NFκB and mitogen activated protein kinase (MAPK) pathways is altered in the presence of lipoxins and resolvins [25-30].”
BackgroundYan, H., Zhou, Y., Liu, Y., Deng, Y., Puthiyakunnon, S., & Chen, X. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23815 · Cited by 74
“miR-146b was upregulated at 24 and 48hr and miR-302d was highly expressed in early exudates [Recchiuti et al., 2011].”
BackgroundResultHalade, G. V., Kain, V., & Serhan, C. N. (2018) · The FASEB Journal · doi:10.1096/fj.201701173rr · Cited by 75
Self-citationn-3 Polyunsaturated Fatty Acids and Their Derivates Reduce Neuroinflammation during Aging
Joffre, C., Dinel, A., Chataigner, M., Pallet, V., & Layé, S. (2020) · Nutrients · doi:10.3390/nu12030647 · Cited by 83
Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust
Nordgren, T. M., Heires, A. J., Wyatt, T. A., Poole, J. A., LeVan, T. D., CERUTIS, D. R., & Romberger, D. J. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-51 · Cited by 74
“It is noteworthy that NFκB activation was not significantly altered by MaR1 treatment in the cells, as reports have shown that omega-3 fatty acids and their derivatives (including resolvin D1, resolvin D5, and resolvin E1), limit NFκB activation, implicating this transcription factor as a key target of various SPM [14…”
BackgroundInfluentialRius, B., Duran‐Güell, M., Flores‐Costa, R., López‐Vicario, C., Lopategi, A., Alcaraz‐Quiles, J., Casulleras, M., José Lozano, J., Titos, E., & Clària, J. (2017) · The FASEB Journal · doi:10.1096/fj.201700394r · Cited by 68
“Therefore and given that previous studies have assigned specific miRNA signatures to SPM actions (33, 43), we next profiled miRNA by next generation sequencing in primary hepatocytes challenged with palmitate in the absence or presence of”
BackgroundNon-Coding RNAs: New Players in Skin Wound Healing
Herter, E. K., & Xu, N. (2017) · Advances in Wound Care · doi:10.1089/wound.2016.0711 · Cited by 72
“Its expression is induced in macrophages by resolving D1, an endogenous lipid mediator produced during inflammation resolution.(49) Also, the level of miR-21 is increased in macrophages after engulfment of apoptotic neutrophils, which is a key process to shift inflammation toward tissue repair.”
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Vartak, T., Godson, C., & Brennan, E. P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113965 · Cited by 72
Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
Recchiuti, A., Patruno, S., Mattoscio, D., Isopi, E., Pomilio, A., Lamolinara, A., Iezzi, M., Pecce, R., & Romano, M. (2021) · The FASEB Journal · doi:10.1096/fj.202001952r · Cited by 68
Self-citationFunctional genomics of pain in analgesic drug development and therapy
Lötsch, J., Doehring, A., Mogil, J. S., Arndt, T., Geißlinger, G., & Ultsch, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.004 · Cited by 70
“Their importance for pain (Niederberger et al., 2011) lies in their therapeutic blockade with so-called “antagomirs”, an upcoming analgesic therapy strategy (Recchiuti et al., 2011).”
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1
Mattè, A., Recchiuti, A., Federti, E., Koehl, B., Mintz, T., Nemer, W. E., Tharaux, P., Brousse, V. A. M., Andolfo, I., Lamolinara, A., et al. (2018) · Blood · doi:10.1182/blood-2018-07-865378 · Cited by 68
Self-citationUmehara, T., Mori, R., Mace, K. A., Murase, T., Abe, Y., Yamamoto, T., & Ikematsu, K. (2018) · Diabetes · doi:10.2337/db18-0313 · Cited by 71
“Reports have described that miRNAs have an important function in several diseases (10) and wound healing, and they have been shown to comprehensively regulate a number of important biological processes within the cell (11,12).”
BackgroundBanerjee, J., & Sen, C. K. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_15 · Cited by 74
“Resolvin D1, an endogenous lipid mediator generated during resolution phase of acute inflammation, induces miR-21, and therefore miR-21 has been proposed to play a role in resolving acute inflammation [22].”
BackgroundLi, Y., Li, J., Belisle, S. E., Baskin, C. R., Tumpey, T. M., & Katze, M. G. (2011) · Virology · doi:10.1016/j.virol.2011.09.011 · Cited by 63
“…miR-21, miR-223, miR-30b, miR-30c, miR30d and miR-98 (Fang et al., 2010; Hu et al., 2009; Iliopoulos et al., 2009; Li et al., 2010a; Lu et al., 2009; Recchiuti et al., 2011; Zhou et al., 2009) have been experimentally shown to affect key regulators in inflammatory response and cell death (Table 2).”
Wang, L., Yuan, R., Yao, C., Wu, Q., Christelle, M., Xie, W., Zhang, X., Sun, W., Wang, H., & Yao, S. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131044 · Cited by 67
“In a peritonitis model RvD1 inhibited neutrophil recruitment, modified the miRNA expression, reduced the expression of cytokines, and relieved inflammation associated with peritonitis.(8,9) RvD1 could also prevent neutrophil recruitment in a murine air pouch model.”
BackgroundTang, H., Liu, Y., Yan, C., Petasis, N. A., Serhan, C. N., & Gao, H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400942 · Cited by 57
“Interestingly, recent studies show that RvD1 reduces NF-kB pathway in human monocytes and macrophages by regulating specific microRNAs (32, 34).”
BackgroundSelf-citationRajasagi, N. K., Bhela, S., Varanasi, S. K., & Rouse, B. T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1216-511rr · Cited by 57
“Moreover, the Serhan group [17] has shown that RvD1 regulates the expression of specific miRNA involved in resolution of inflammation.”
BackgroundRecchiuti, A., Mattoscio, D., & Isopi, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00252 · Cited by 64
“Identified target genes of these microRNAs include IL-8, IL-10, and 5-LO that have pivotal roles in acute inflammation (Recchiuti et al., 2011; Krishnamoorthy et al., 2012).”
BackgroundSelf-citation
Metadata
- Authors
- Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2010-10-18
- Volume
- 25
- Issue
- 2
- Pages
- 544-560
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3023392
- OpenAlex
- W2039265368
- Cited by
- 292
- References
- 51
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 25 · 2019: 25 · 2018: 18 · 2017: 21 · 2016: 16 · 2015: 17 · 2014: 25 · 2013: 31 · 2012: 26
- FWCI
- 22.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R37GM38765, R01DK074448, R01DE019938)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- microRNA, inflammation resolution, resolvin D1, acute inflammation, peritonitis, miR-146b, miR-21, miR-219, miR-208a, zymosan, neutrophil infiltration, FPR2/ALX, NF-κB signaling, 5-lipoxygenase, leukotriene biosynthesis, Smad, macrophages
- MeSH terms
- Acute Disease, Animals, Docosahexaenoic Acids, Gene Expression Regulation, Inflammation, Peritonitis, Recombinant Proteins, Zymosan, Polymerase Chain Reaction, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.